CG
MRNA icon

Caprock Group’s Moderna MRNA Stock Holding History

Caprock Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$454K Buy
+8,946
New +$417K 0.01% 780
2025
Q4 		– Sell
-13,884
Closed -$334K – 1265
2025
Q3 		$334K Buy
+13,884
New +$387K 0.01% 914
2025
Q1 		– Sell
-4,886
Closed -$203K – 1143
2024
Q4 		$203K Buy
+4,886
New +$234K 0.01% 935
2024
Q3 		– Sell
-5,122
Closed -$608K – 951
2024
Q2 		$608K Buy
5,122
+2,040
+66% +$258K 0.02% 489
2024
Q1 		$328K Buy
3,082
+621
+25% +$62.6K 0.02% 527
2023
Q4 		$245K Sell
2,461
-42
-2% -$3.53K 0.02% 593
2023
Q3 		$258K Buy
+2,503
New +$279K 0.02% 538

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caprock Group's MRNA Position: Q1 2026 in Review

Caprock Group opened a new position in Moderna (MRNA) in Q1 2026: 8,946 shares worth $454K. The stake represents 0.01% of the portfolio and ranks #780 among its holdings. This is a return to the name: Caprock Group previously reported a position in MRNA as recently as Q3 2025.

Caprock Group first reported a position in MRNA in Q3 2023 and has held it in 7 quarters since. The position peaked at $608K in Q2 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Caprock Group held 8,946 shares of Moderna worth $454K as of Q1 2026.
  • Moderna was a new Caprock Group position in Q1 2026.
  • Moderna made up 0.01% of Caprock Group's portfolio in Q1 2026, its #780 holding.
  • Caprock Group first reported a position in Moderna in Q3 2023 and has held it in 7 quarters since.
  • Caprock Group's Moderna position peaked at $608K in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.